<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus type 1 (HIV-1) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is known to increase the incidence of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Parallels with other causes of <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> suggest a possible effect of HIV-1 on additional <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PURPOSE: This study was designed to determine the types and rates of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> occurring in excess in the presence of HIV-1 infection </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We examined <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in a population-based open cohort with a high prevalence of HIV-1 infection </plain></SENT>
<SENT sid="4" pm="."><plain>The study population was never-married men aged 25-54 years who resided in San Francisco, Calif., of whom an estimated 20,000 (24%) were HIV-1 seropositive as of late 1984 </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> registration data covering 1,390,000 person-years of observation of these men from 1973 through 1990 were obtained from the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute's Surveillance, Epidemiology, and End Results (SEER) Program </plain></SENT>
<SENT sid="6" pm="."><plain>Standardized incidence rates and ratios of observed to expected cases (based on rates in the pre-acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome [pre-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>] period [i.e., 1973-1979]) were calculated for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> classified by site and by cell type </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The incidence of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> in never-married men plateaued in 1988-1990 at 0.5% per year </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> increased 20-fold between 1973-1979 and 1988-1990; increases were most pronounced in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of higher grade histology and extranodal (especially central <z:mp ids='MP_0008912'>nervous</z:mp> system) primary sites </plain></SENT>
<SENT sid="9" pm="."><plain>The incidence of Burkitt's and Burkitt-like <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> peaked in 1985-1987, whereas that of large cell diffuse and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> increased throughout the study period </plain></SENT>
<SENT sid="10" pm="."><plain>The incidence of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> was 2.0 (95% confidence interval [CI] = 1.3-3.0) times expected in 1988-1990 </plain></SENT>
<SENT sid="11" pm="."><plain>The incidence of <z:e sem="disease" ids="C0153446" disease_type="Neoplastic Process" abbrv="">anal cancer</z:e> was 9.9 (95% CI = 4.5-18.7) times expected in 1973-1979 and 10.1 (95% CI = 5.0-18.0) times expected in 1988-1990 </plain></SENT>
<SENT sid="12" pm="."><plain>Ratios of observed to expected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> of most other sites were 2.0 or less; the ratio of <z:hpo ids='HP_0100243'>leiomyosarcomas</z:hpo> (at any site) was 2.5 (95% CI = 0.5-7.4) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: As the HIV-1 epidemic has progressed, the increases in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo>, <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumor</z:e>, and other non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have followed different patterns </plain></SENT>
<SENT sid="14" pm="."><plain>The effect of HIV-1 on other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> has been nondetectable </plain></SENT>
<SENT sid="15" pm="."><plain>In particular, HIV-1 is not related to the increased risk of <z:e sem="disease" ids="C0153446" disease_type="Neoplastic Process" abbrv="">anal cancer</z:e> in homosexual men, which antedated the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> epidemic </plain></SENT>
<SENT sid="16" pm="."><plain>IMPLICATIONS: These data suggest that the etiologic mechanisms of HIV-1-related <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> differ for specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and do not globally increase <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="17" pm="."><plain>Control of HIV-1-related <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> remains an unsolved challenge in the management of HIV-1 infection </plain></SENT>
</text></document>